• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD MAXGUARD¿ EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. BD MAXGUARD¿ EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number ME2017
Medical Device Problem Codes Leak/Splash (1354); Material Separation (1562)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/29/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that the bd maxguard¿ extension set tubing snapped in half and leaked during use.The following information was provided by the initial reporter: "syringe tubing snapped in half when rn went to place label on it.Syringe tubing already in line with morphine continuously infusing to patient.Patient had a 1 minute pause in their continuous morphine and required new tubing to be primed and reattached to lines." "did you experienced any leakage due to the reported failure? yes.Pump was paused immediately and no harm came to patient.".
 
Additional Manufacturer Narrative
One extension set was received and tested by our quality team.The separation was immediately apparent, and the complaint was verified.After visual analyses under microscope, the failure was found to be a lack of solvent applied to the tubing to female luer junction during production.The manufacturing team has been notified and they have issued a quality alert to eliminate further occurrences of this failure.A device history record review could not be performed because a lot number was not provided by the customer.
 
Event or Problem Description
It was reported that the bd maxguard¿ extension set tubing snapped in half and leaked during use.The following information was provided by the initial reporter: "syringe tubing snapped in half when rn went to place label on it.Syringe tubing already in line with morphine continuously infusing to patient.Patient had a 1 minute pause in their continuous morphine and required new tubing to be primed and reattached to lines." "did you experienced any leakage due to the reported failure? yes.Pump was paused immediately and no harm came to patient.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAXGUARD¿ EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key15366937
Report Number9616066-2022-01286
Device Sequence Number13852053
Product Code FPA
UDI-Device Identifier10885403236242
UDI-Public10885403236242
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K051499
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberME2017
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/19/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/12/2022
Supplement Date Received by Manufacturer11/01/2022
Initial Report FDA Received Date09/06/2022
Supplement Report FDA Received Date11/11/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-